balloon catheter Articles
-
Chronic Total Occlusion – Left Anterior Descending Proximal to Mid Lesion - Case study
Overview Dr. Craig Rosen used the Teleport® Microcatheter and several Sapphire® II PRO and Sapphire® NC Plus PTCA Balloons to perform a proximal to mid left anterior descending coronary artery (LAD) revascularization of a chronic total occlusion using stents. Patient History A 60-year-old Caucasian male patient with a BMI of 29, so overweight but not obese, presented ...
-
Chocolate PTCA Balloon Catheter for pre-dilatation of an occluded right coronary artery - Case Study
Incomplete stent expansion and malapposed stent struts are a predictor of subacute and late stent thrombosis. Appropriate lesion preparation prior to stent implantation is necessary to assure complete stent expansion and stent strut apposition. This is of particular importance in challenging lesions, in particular those with calcific plaque. The goal of the pre-dilatation is to obtain optimal ...
-
Chocolate PTCA Balloon Catheter for pre-dilatation of an occluded circumflex and second obtuse marginal arteries - Case Study
Incomplete stent expansion and malapposed stent struts are a predictor of subacute and late stent thrombosis. Appropriate lesion preparation prior to stent implantation is necessary to assure complete stent expansion and stent strut apposition. This is of particular importance in challenging lesions, in particular those with calcific plaque. The goal of the pre-dilatation is to obtain optimal ...
-
Alucent Biomedical Re-Envisioning PAD Treatment with a Natural Vascular Scaffold
Start-up Alucent Biomedical is using a light-activated molecule, delivered via a balloon catheter, to create a natural vascular scaffold in diseased peripheral vessels, with the aim of providing a long-lasting treatment option that maintains patency while leaving nothing behind in the vessel. Alucent Biomedical Inc. is rethinking peripheral artery disease (PAD) treatment with a novel natural ...
-
APBI with VeraForm & SAVI Brachytherapy: Marking for the Unpredictable
Our Medical Director of the Oncology Breast Program, Dr. Beth DuPree, was first in the U.S. to adopt VeraForm, a continuous, radiopaque 3D tissue marker. Within months, its utility led to quick integration into our program’s standard daily practice. Like all centers today, patient satisfaction is a focal point and to date, we have seen no complications or toxicities by any criteria (e.g., ...
-
A Contemporary Review of ST-Elevation Myocardial Infarction: Pathophysiology, treatment options and hot topics
Pathophysiology, treatment options and hot topics Improvements In Stemi Treatment The immediate and long-term prognosis of patients experiencing an ST segment elevation myocardial infarction (STEMI) has changed dramatically since the introduction of coronary reperfusion therapies during primary percutaneous coronary intervention (pPCI). The evolution of these therapies accelerated with the ...
-
Physiology and Pathology of Coronary Microcirculation
The heart is a unique organ in many respects since its activity is mandatory to sustain life. The heart’s circulatory system and coronary flow regulation are highly adapted to the vital role of the heart in sustaining life and to everyday physiological challenges. Understanding coronary physiology is key for treating patients with ischemic heart disease in general, and ...
-
Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure
Abstract Acute decompensated heart failure remains the most common cause of hospitalization in older adults, and studies of pharmacological therapies have yielded limited progress in improving outcomes for these patients. This has prompted the development of novel device–based interventions, classified mechanistically based on the way in which they intend to improve central hemodynamics, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you